- Corporate Officers - K
- Kenyon Lawrence A
Insider Trading History of Kenyon Lawrence A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kenyon Lawrence A since 2007.
This trader's CIK number is 1230484.
At the time of last reporting, Kenyon Lawrence A was the Chief Financial Officer of Outlook Therapeutics, Inc.. (stock ticker symbol OTLK).
Also see all insider trading activities at Outlook Therapeutics, Inc..
Note that in the past
KENYON LAWRENCE A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Outlook Therapeutics, Inc. (OTLK) by Kenyon Lawrence A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | OTLK | 5,000 | $28,445 | 0 | $0 | 0 | $0 |
| 2021 | OTLK | 10,000 | $18,300 | 0 | $0 | 0 | $0 |
| 2019 | OTLK | 25,000 | $22,375 | 1,350 | $2,295 | 0 | $0 |
| 2018 | OTLK | 0 | $0 | 10,100 | $8,807 | 0 | $0 |
| 2017 | OTLK | 0 | $0 | 26,165 | $29,566 | 0 | $0 |
Yearly summary of insider trading at Alfacell Corp (ACEL) by Kenyon Lawrence A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | ACEL | 25,000 | $53,900 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Par Pharmaceutical Companies, Inc. (PRX) by Kenyon Lawrence A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | PRX | 0 | $0 | 21,439 | $540,713 | 21,439 | $279,993 |
Insider trading activities at 3 companies by Kenyon Lawrence A:
1. Outlook Therapeutics, Inc. (OTLK)
2. Alfacell Corp (ACEL)
3. Par Pharmaceutical Companies, Inc. (PRX)
Table 1. Insider trading of Outlook Therapeutics, Inc. (OTLK) by Kenyon Lawrence A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-09-26 | OTLK | Buy | 5,000 | 5.69 | 28,445 |
| 2021-04-20 | OTLK | Buy | 10,000 | 1.83 | 18,300 |
| 2019-09-18 | OTLK | Sale | 1,350 | 1.70 | 2,295 |
| 2019-02-07 | OTLK | Buy | 25,000 | .90 | 22,375 |
| 2018-09-18 | ONS | Sale | 10,100 | .87 | 8,807 |
| 2017-12-22 | ONS | Sale | 26,165 | 1.13 | 29,566 |
Table 2. Insider trading of Alfacell Corp (ACEL) by Kenyon Lawrence A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-04-11 | ACEL | Buy | 25,000 | 2.16 | 53,900 |
Table 3. Insider trading of Par Pharmaceutical Companies, Inc. (PRX) by Kenyon Lawrence A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-03-03 | PRX | Sale | 21,439 | 25.22 | 540,713 |
| 2010-03-03 | PRX | Option Ex | 21,439 | 13.06 | 279,993 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kenyon Lawrence A
(Chief Financial Officer of Outlook Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.